NDC 0069-1318 – Retacrit

Epoetin 10000 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug

Product NDC0069-1318

Product details

Brand name
Retacrit
Generic name
Epoetin alfa-epbx
Labeler
Pfizer Laboratories Div Pfizer Inc
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
BLA · BLA125545
Marketed since
November 9, 2020
Listing expires
December 31, 2026
Pharmacologic class
Erythropoiesis-stimulating Agent

Active ingredients

Uses, dosage, side effects and warnings for Retacrit →

Package NDC codes (1)

Package NDCDescriptionSince
0069-1318-1010 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-10) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01)Nov 9, 2020

Other Retacrit products